A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
Clinical trial NCT06672978 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06672978
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-03
- Primary completion
- 2027-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.